Trillium Asset Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.6M Buy
302,395
+57,932
+24% +$6M 0.94% 26
2026
Q1
$24.2M Buy
244,463
+26,729
+12% +$2.74M 0.8% 39
2025
Q4
$23.4M Buy
217,734
+11,793
+6% +$1.37M 0.72% 44
2025
Q3
$26.2M Buy
205,941
+618
+0.3% +$73.6K 0.69% 46
2025
Q2
$25.2M Buy
205,323
+44,490
+28% +$5.08M 0.68% 47
2025
Q1
$16.3M Buy
160,833
+343
+0.2% +$33.5K 0.47% 68
2024
Q4
$14.8M Sell
160,490
-2,302
-1% -$226K 0.38% 79
2024
Q3
$15.7M Buy
162,792
+103,868
+176% +$9.33M 0.39% 77
2024
Q2
$5.06M Buy
58,924
+5,252
+10% +$441K 0.13% 140
2024
Q1
$4.43M Buy
+53,672
New +$3.93M 0.11% 138

Other funds holding EHC

Trillium Asset Management's EHC Position: Q2 2026 in Review

Trillium Asset Management increased its Encompass Health (EHC) stake by 24% in Q2 2026, buying an estimated $6M and bringing the position to 302,395 shares worth $30.6M. The position accounts for 0.94% of the portfolio, ranked #26.

Trillium Asset Management first reported a position in EHC in Q1 2024 and has held it in 10 quarters since. 597 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Trillium Asset Management held 302,395 shares of Encompass Health worth $30.6M as of Q2 2026.
  • Trillium Asset Management bought 57,932 Encompass Health shares in Q2 2026, an estimated $6M.
  • Encompass Health made up 0.94% of Trillium Asset Management's portfolio in Q2 2026, its #26 holding.
  • Trillium Asset Management first reported a position in Encompass Health in Q1 2024 and has held it in 10 quarters since.
  • 597 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Trillium Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.